The use of diazoxide in hypertension with renal damage. 1971

J E Pohl, and H Thurston

UI MeSH Term Description Entries
D006974 Hypertension, Malignant A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction. Malignant Hypertension
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D003981 Diazoxide A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. Hyperstat,Proglycem
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J E Pohl, and H Thurston
January 1972, Drug and therapeutics bulletin,
J E Pohl, and H Thurston
December 1963, Archives of internal medicine,
J E Pohl, and H Thurston
January 1975, Clinical nephrology,
J E Pohl, and H Thurston
January 1977, Duodecim; laaketieteellinen aikakauskirja,
J E Pohl, and H Thurston
May 1979, Anaesthesia and intensive care,
J E Pohl, and H Thurston
November 1979, Anaesthesia and intensive care,
J E Pohl, and H Thurston
November 1978, Anaesthesia and intensive care,
J E Pohl, and H Thurston
August 1974, Missouri medicine,
J E Pohl, and H Thurston
January 2019, Drug, healthcare and patient safety,
Copied contents to your clipboard!